Stacy L. Chin says SBIR funding now rewards precision over volume. Founders must name their end-users, prove demand exists, and show a clear path to Phase 3 commercialization before writing the proposal. Vague commercialization plans no longer work.
For first-time founders, this fundamentally changes the approach from volume to precision, and the implication is clear: strong fit is now prerequisite, not a bonus. So what should you do is to narrow your focus to one or two high-fit opportunities and ensure your proposal is tightly aligned before you submit. Who actually buys your tech? If you can't name who's gonna buy your tech, then don't expect SBIR to fund it. The program is no longer just backing interesting research. It's prioritizing technologies that have a clear path to Phase 3 or commercialization or real-world uses. Most founders still focus on the nitty-gritty science and leave commercialization vague, which is exactly why their proposals will get passed over. Because reviewers now are looking for signals of demand upfront, not just an afterthought. If your end user isn't obvious, your proposal isn't competitive. So figure out exactly who will adopt your solution, name them, and validate the need before you write a single word.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
